Stephen Landreneau, MD
Gastroenterology · New Orleans, LANPI 1578630232
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Cook Medical LLC accounts for 70.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $11,178 and has fallen 93.5% since, to $726 in 2025.
Across 213 payments — averaging $81.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$12K
- Wilson Cook Medical Incorporated$2K
- Boston Scientific$822
- AbbVie$611
- Takeda Pharmaceuticals U.S.A., Inc.$500
- Pfizer$259
- plus $1K from 17 others
What the payments were for
- Consulting fees$1,4008%
- Travel & lodging$4393%
- Food & beverage$5,48632%
- Education$10,00058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 48 | $12,231 |
| Wilson Cook Medical Incorporated | 3 | $1,839 |
| Boston Scientific | 33 | $822 |
| AbbVie(2 entities) | 32 | $611 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $500 |
| Pfizer | 13 | $259 |
| Gilead | 14 | $254 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $192 |
| Johnson & Johnson | 8 | $136 |
| Bristol Myers Squibb | 4 | $95 |
| QOL Medical, LLC | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Shire North American Group Inc | 2 | $35 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Sanofi | 1 | $31 |
| Orphalan Inc | 1 | $27 |
| Novo Nordisk | 1 | $25 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Biofire Diagnostics, LLC | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| AstraZeneca | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Endoscopic Ultrasound$10,000
- Cook Medical Sphincterotomy$1,839
- Hemospray$214
- ACQUIRE$159
- Cook Medical Biliary$128
- Fusion Quattro$113
- EXALT MODEL D CONTROLLER$104
- EchoTip$103
How this compares
$17,326 in reported general payments places this provider in the 85th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $704 |
| Pantoprazole Sodium | 40 | $504 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New Orleans
- Sarah GloverNew Orleans$274K
- Nisha LoganantharajNew Orleans$173K
- Shamita ShahNew Orleans$114K
- Vivek HuilgolNew Orleans$37K
- Arnab RayNew Orleans$26K
- Janak ShahNew Orleans$18K
- Virendra JoshiNew Orleans$16K
- Parth ParekhNew Orleans$10K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.